Patent Infringement Claims Over Generic Enalapril To Proceed In Delaware
WILMINGTON, Del. — A request by a generic drugmaker for judgment on the pleadings that “third wave” patent infringement claims by the maker of a brand name hypertension drug are precluded...To view the full article, register now.
Already a subscriber? Click here to view full article